Coherus announces positive Phase II results for cancer treatment
Coherus BioSciences shared final data from its Phase II trial of casdozokitug, showing a 17.2 percent complete response rate in...
Coherus BioSciences shared final data from its Phase II trial of casdozokitug, showing a 17.2 percent complete response rate in...
To support veterans at risk for or living with liver disease, the American Liver Foundation (ALF) has partnered with the...
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients...
Winners to receive $10,000 honorary donation to a health charity of their choice, courtesy of Echosens PARIS, Aug. 26, 2024...
Calyxo, Inc., a medical device company developing innovative solutions for patients with kidney stones, has announced positive new study results...
CVAC System (Photo: Business Wire)CVAC System ProcedureMulti-Center ASPIRE 1-Year Study Results Show Healthcare Consumption Events are Significantly Lower after SURE...